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Summary
 
Apoptosis is a genetically programmed series of events that results in cell death. As a conse-
quence, it is difficult to identify dominant genes that play a role in this process using genetic se-
lections in conventional cell culture systems. Accordingly, we have established an efficient ex-
pression screen to isolate dominant, apoptosis-inducing genes. The assay is based on the
apoptotic morphology induced in the human kidney cell line 293 after transient transfection of
small plasmid pools from normalized cDNA expression libraries. Using this assay, we isolated a
novel isoform of the proto-oncogene Neu differentiation factor (NDF), a ligand for erbB re-
ceptor tyrosine kinases. Several lines of experimental evidence indicate that this gene kills in a
cell-autonomous fashion and independently of known erbB receptors. This apoptotic property
of an NDF isoform is readily contrasted with NDF’s transforming potential and might balance
the tendency to tumorigenesis in cells that overexpress NDF.
 
C
 
onsiderable progress has been made in unraveling the
genetic elements of programmed cell death in lower
organisms such as 
 
Caenorhabditis elegans
 
 and 
 
Drosophila mela-
nogaster
 
 (1, 2). Higher mammalian systems might possess
even more elaborate genetic pathways leading to the induc-
tion of apoptosis. However, since mammals are less amen-
able to genetic manipulation, our knowledge of their rele-
vant genes might still be largely incomplete. Two genetic
approaches in mammalian cells have been described which
facilitate the isolation of genes that inhibit apoptosis (3, 4).
Due to the transient apoptotic phenotype and the subse-
quent disappearance of the dead cells, the isolation of dom-
inant genes that lead to the induction of apoptosis did not
seem practical. Nonetheless, here we report a simple ge-
netic screen for dominant, apoptosis-inducing genes that is
based on easily scored morphological changes in apoptotic
cells. Using this screen, we have isolated a novel isoform of
the precursor protein for the protooncogene NDF (Neu
differentiation factor) which induces apoptosis on overex-
pression.
 
Materials and Methods
 
Isolation of Apoptosis-inducing Genes.
 
Kidney mRNA from 4–6-
wk-old FVB mice was normalized as described (5). The proce-
dure uses the rapid association of abundant mRNA species with
their cDNAs covalently attached to latex beads which are subse-
quently removed by centrifugation. After two rounds of hybrid-
ization, 200 ng (of initially 2 
 
m
 
g) mRNA were retrieved and used
to generate a cDNA library with a cDNA synthesis kit (GIBCO
BRL, Gaithersburg, MD). After ligation of a BstXI adaptor (In-
vitrogen, San Diego, CA) and a NotI digest, the cDNAs were
inserted into a modified pcDNA3 vector (Invitrogen) in which the
neomycin resistance gene had been deleted. The DNA was elec-
troporated into 
 
Escherichia coli
 
 SURE cells (Stratagene Corp., La
Jolla, CA) which were immediately frozen. Plating of aliquots re-
 
vealed that the library contained 
 
z
 
1.1 
 
3
 
 10
 
5
 
 independent clones.
Aliquots corresponding to 20 clones were thawed and grown up.
Miniprep DNA was isolated as described (6) and transfected into
293 cells in 24-well plates using the calcium phosphate co-precip-
itation method. After 18 h, the cells were inspected for apoptosis
induction with phase contrast microscopy. The bacteria pool whose
plasmid DNA caused morphological signs of apoptosis in 293
cells was spread on plates. Plasmid DNAs from individual bacteria
colonies were again transfected into 293 cells to isolate the active
clone.
 
Cell Transfections.
 
Plasmid DNAs were isolated with Qiagen
columns (Qiagen, Chatsworth, CA) and transfected into 293 or
baby hamster kidney (BHK) cells with the calcium phosphate co-
precipitation method as described (7).
 
Expression Constructs.
 
The deletion mutants of 
 
b
 
2b NDF were
created with PCR using suitable primers encompassing the 
 
b
 
2b
NRG Kozak sequence, 200 ng template, and 20 cycles with Pwo
(Boehringer Mannheim, Indianapolis, IN) which has proofread-
ing activity. All constructs were transcribed and translated in vitro
(TNT kit; Promega Corp., Madison, WI), and yielded products of
the expected sizes (not shown). In each case, two NDF expres-
sion constructs were generated by two independent PCR reac-
tions.
 
Quantitative Apoptosis Assay.
 
BHK cells were transfected with
the respective plasmids and a 
 
b
 
-galactosidase (
 
b
 
-gal) expression
vector. When PCR-generated NDF deletion constructs were
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used, two independently generated constructs were transfected in
two transfections each. 24 h later the cells were stained with X-gal
and the extent of apoptosis was measured by counting morpho-
logically apoptotic blue cells and determining their percentage of
the total number of blue, transfected cells (8).
 
DNA Isolation.
 
Low molecular weight DNA was isolated by
lysing the cells with 0.2% Triton X-100 on ice for 10 min. After
centrifugation, low molecular weight DNA was recovered in the
supernatant and phenol-extracted. The samples were loaded on a
2% agarose gel after RNA digestion.
 
Reverse Transcription PCR.
 
Total RNA was isolated (RNAstat;
Tel-Test Inc., Friendswood, TX) from the indicated tissues from
two 6-wk-old FVB mice. For the reverse transcriptase (RT)
PCR, 2 
 
m
 
g of total RNA were reverse transcribed with oligo dT
primers in a volume of 30 
 
m
 
l. 5 
 
m
 
l were used in a PCR reaction
with primers for 
 
b
 
-actin (Clontech, Palo Alto, CA), an oligo (5
 
9
 
-
AGCTTCTACAAAGCGGAG-3
 
9
 
) that spans the junction be-
tween the 
 
b
 
 and the 2 exon of 
 
b
 
2b NDF (hybridizing to 8 bp of
the 2 exon and 10 bp of the b exon) and a primer (5
 
9
 
-ATATCT-
AGATAAAGGCCAAGGGGTC-3
 
9
 
) that was complementary to
the 
 
b
 
 exon of 
 
b
 
2b NDF. DNA templates for 
 
b
 
-actin (
 
z
 
17 pg)
and 
 
b
 
2b NDF (
 
z
 
200 pg) were used as positive controls, reverse
transcribed tRNA was used as a negative control. An initial dena-
turation time of 1 min and 25 cycles of 30 s at 94
 
8
 
C, 1 min at
52
 
8
 
C, and 1 min at 68
 
8
 
C were used in the PCR. The reaction
products were separated on 1% agarose gels and blots probed with
mouse 
 
b
 
-actin or 
 
b
 
2b NDF, respectively.
Primers for erbB receptors, amplification conditions, and hybri-
dization with internal oligonucleotide probes were as described (9).
 
Results
 
Reasoning that the machinery for apoptosis might al-
ready exist in latent form in dynamic organs (10), we used
normal mouse kidney as a RNA source for constructing an
Figure 1. Outline of the assay for cloning apoptosis-inducing genes.
After normalization of the mRNA, a library was constructed in a mam-
malian expression vector. DNAs from pools of z20 bacteria clones were
transiently transfected into 293 cells. The bacteria of the pool which in-
duced morphological signs of apoptosis in cells (as indicated in the figure
by a cell with altered shape) were plated and individual clone DNAs were
once more transiently transfected. The positive clone was again identified
by inspecting the cells for apoptosis induction.
Figure 2. Apoptosis induction by the isolated expression plasmid. 293 cells were transiently transfected with the empty vector (A) or the isolated plas-
mid clone (B). After 12 h, incubation phase contrast pictures at a 320-fold magnification were taken. (C) Expression of the isolated clone leads to DNA
degradation. 293 cells were transfected with the vector (lane 1) or with the expression plasmid DNA (lane 2). After 16 h, low molecular weight DNA was
isolated, separated on a 2% agarose gel, and stained with ethidium bromide. 
1139
 
Grimm and Leder Brief Definitive Report
 
expression library. To reduce the redundancy of the mRNA,
we normalized its sequence representation (5). From the
resulting, unamplified cDNA library, small aliquots were
grown up and plasmid miniprep DNAs were transfected into
the human kidney cell line 293 (Fig. 1). This cell line has
the advantage of being highly transfectable and producing
an obvious apoptotic phenotype with membrane blebbing
and subsequent shrinkage of the cytoplasm. After screening
480 pools (
 
z
 
10% of the library) by phase contrast micros-
copy for apoptosis induction, a positive plasmid pool was
detected. A single apoptosis-inducing cDNA clone was iso-
lated from this pool (Fig. 2). Transfection of as little as 200 ng
of this plasmid brought about apoptosis (not shown). Sub-
sequent experiments demonstrated that this gene could also
induce apoptosis in the hamster BHK cell line (see Fig. 4),
emphasizing the phylogenetic conservation of this function.
Isolation of low molecular weight DNA after transfecting
the expression plasmid into 293 cells revealed nucleosomal
DNA fragmentation, a biochemical hallmark of apoptosis
(11; Fig. 2 
 
C
 
).
The 2.7-kb insert cDNA was sequenced and was surpris-
ingly identified as a member of the NDF family (12, 13).
NDF is a ligand for erbB receptor tyrosine kinases, some of
which have been implicated in a variety of human carcino-
mas (14). NDF gives rise to multiple alternative splice forms
which code for transmembrane precursor proteins from
which the secreted NDF molecules are proteolytically gen-
erated. The particular isoform described here contains the
 
b
 
, 2, and b exons (see Fig. 4). This combination of exons
has not been previously described, establishing 
 
b
 
2b NDF as
a novel isoform of NDF. No sequence resemblance to genes
known to be involved in apoptosis could be detected in the
database. Subsequently, RT-PCR was used to determine
the expression pattern of 
 
b
 
2b NDF in mice (Fig. 3). The
results indicate that it is expressed at similar levels in most
tissues examined with higher amounts in brain and in stom-
ach. Colon and muscle did not produce a signal in this ex-
periment; however, extensive PCR amplification revealed
low levels of expression in these organs as well (not shown).
Since the NDF precursor proteins are composed of mul-
tiple subdomains, we wished to delineate those domains
that are involved in apoptosis induction. Therefore, we en-
gineered several deletion mutants of 
 
b
 
2b NDF and scored
their ability to induce apoptosis after transient transfection
in BHK cells. Fig. 4 shows that deleting the immunoglobu-
lin homology domain (
 
IG
 
) reduced apoptosis induction by
68%. Further deletions into the epidermal growth factor
homology domain abrogated the ability of 
 
b
 
2b NDF to
cause cell death. However, mutant 
 
D
 
 2–198 could weakly
induce apoptosis in 293 cells which are more susceptible to
cell death induction (not shown). Overexpression of an-
other mutant encompassing only the cytoplasmic domain
of 
 
b
 
2b NDF was also inactive in 293 cells (not shown). In-
terestingly, the intracellular portion, which is not part of
the secreted moiety (15), was necessary for apoptosis induc-
Figure 3. Expression profile of b2b NDF in mice as measured by RT-
PCR. b2b NDF-specific primers were used to amplify a 724-bp long
DNA. The efficiency of the RT reaction was controlled by co-amplifying
a 540-bp long b-actin fragment. Both products were detected by South-
ern blotting. The b2b NDF blot was exposed for 12 h, and the b-actin
blot for 2 h.
Figure 4. Mapping of the apoptosis-inducing domains in b2b NDF
with deletion mutants in BHK cells. The various domains are indicated
on top of the diagrammatic representation of wild-type b2b NDF. IG,
immunoglobulin domain; Glyco, glycosylated domain; EGF, epidermal
growth factor homology domain; b, sequences of b exon; 2, sequences
from exon 2; TM, transmembrane domain; Cyto, cytoplasmatic domain;
b, sequences from exon b. The names of the deletion mutants indicate the
deleted amino acids. Wild type or the deletion mutants of b2b NDF (4 mg)
were transfected into BHK cells together with a marker plasmid (1 mg)
for b-gal staining. 24 h after transfection the cells were stained with X-gal
and the extent of apoptosis was measured by counting morphologically
apoptotic, blue cells and determining their percentage of the total number
of blue, transfected cells. Shown are the means and the standard deviation
of a total of at least 1,000 counted cells from four independent experi-
ments. 
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tion (construct 
 
D
 
 263–460 in Fig. 4). The importance of
the intracellular domain of 
 
b
 
2b NDF is also emphasized by
a mutant with a deletion of the b exon corresponding to
the recently described 
 
b
 
2c NDF isoform (16). Its expres-
sion led to a 66% reduction in apoptosis. These data suggest
that NDF does not act as a secreted molecule in cell death
induction (see below).
The supernatant from NDF-transfected 293 cells was able
to induce receptor tyrosine phosphorylation in MCF-7 cells
indicating that 293 cells can faithfully process 
 
b
 
2b NDF
proteins (not shown). To further investigate whether a re-
ceptor–ligand interaction is involved in this apoptosis in-
duction, we used a sensitive RT-PCR approach to detect
the presence of erbB receptors. In accordance with previ-
ous reports (9, 17), no expression of NDF-binding erbB genes
(erbB-3 and erbB-4) could be detected in 293 cells. How-
ever, erbB-2, which is unable to bind NDF (18), is expressed
in 293 cells (Fig. 5 
 
A
 
). Stably transfecting erbB-2 and erbB-3
or transient co-transfection of a dominant-negative erbB-2
mutant (19) had no effect on 
 
b
 
2b NDF’s apoptosis induc-
tion (not shown). Furthermore, cells lying adjacent to NDF-
transfected cells showed no signs of apoptosis (Fig. 5 
 
B
 
).
These results, the isolated appearance of apoptotic cells af-
ter transient transfection of 
 
b
 
2b NDF (see Fig. 2 
 
B
 
), and
the observation that the supernatant from transfected 293
cells did not induce cell death in untransfected cells (not
shown) indicate that 
 
b
 
2b NDF exerts its apoptotic effect
cell-autonomously and independently of known erbB re-
ceptors.
To integrate the apoptotic signal initiated by 
 
b
 
2b NDF
into the cell death signal transduction pathway, we tried to
block cell death with known inhibitors of apoptosis. Both,
Figure 5. Characterization of the apoptotic signal generated by b2b
NDF. (A) Absence of NDF-binding erbB receptors in 293 cells as de-
tected by RT-PCR. RNAs of the human mammary cell line MCF-7 and
293 cells were amplified, with or without earlier treatment with RT, with
specific primers for the indicated genes. The PCR products were sepa-
rated in agarose gels, blotted onto filters, and hybridized with gene-spe-
cific probes. b-actin was amplified to demonstrate the efficiency of the
RT reactions. (B) Cells adjacent to NDF-transfected cells do not undergo
apoptosis. BHK cells were transfected with the empty vector or b2b NDF
(4 mg each) together with the marker plasmid for b-gal (1 mg), and apop-
tosis was monitored as in Fig. 4. Apoptosis was also measured in cells sur-
rounding NDF-transfected, nonapoptotic (a) and apoptotic (b) cells. (C)
b2b NDF-induced apoptosis is inhibitable by the ICE proteases inhibitor
p35. BHK cells were transfected with b2b NDF (2 mg) and vector,
CrmA, or p35 expression plasmids (2 mg). Apoptosis induction was mea-
sured as in Fig. 4. 
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Bcl-2 and Bcl-x, the prototypical apoptosis repressors (20),
were capable of reducing cell death when co-transfected with
 
b
 
2b NDF (not shown). A 2.8-fold repression of apoptosis
was observed when baculovirus p35, an ICE protease in-
hibitor (21), was co-transfected indicating an activation of
ICE-cysteine proteases in NDF-mediated apoptosis (Fig. 5 
 
C
 
).
Interestingly, other inhibitors of ICE-like proteases, such as
the cowpox gene CrmA (22), was without any effect (Fig.
5 
 
C
 
), as were the tetrapeptide ZVAD-FMK (23) and Ich-1s
(24) (not shown).
 
Discussion
 
In this study we have described the isolation of the novel
 
b
 
2b NDF splice variant using a genetic screen for domi-
nant, apoptosis-inducing genes. The isolation of this gene
was unexpected. Though NDF was known to cause cellu-
lar responses of proliferation or growth arrest (13, 25), its
isolation as an inducer of apoptosis was surprising. Since the
 
b
 
2c isoform of NDF has been shown to function as an on-
cogene when overexpressed (16), it is worth noting that
several other oncogenes, most notably c-myc (26), partici-
pate in seemingly contradictory responses characterized by
proliferation or cell death. However, in contrast to these
oncogenes, NDF’s apoptosis induction is separated from the
transformation process, since it can induce apoptosis in cells
which do not express NDF-binding receptors. The secreted
portion of NDF, which is identical between the 
 
b2c and
b2b NDF isoforms, could therefore act as an oncoprotein
by engaging erbB receptor tyrosine kinases in neighboring
cells, while the intracellular portion determines its apoptosis
induction. Both functions are activated when NDF is over-
expressed, but apoptosis induction can kill the NDF-over-
producing cell and might thereby protect the organism
against tumorigenesis. A functional role for the intracellular
domain of NDF has hitherto been unclear, but is suggested
by its evolutionary conservation (15). The different apop-
totic activities of NDF splice variants in the intracellular do-
main might allow distinct expression levels in normal de-
velopment without the induction of apoptosis.
Tumorigenesis by NDF overexpression would therefore
require the inactivation of its apoptosis pathway. The genes
in this signaling cascade are therefore good candidates for
the “second hits” required for tumorigenesis which renders
our findings an interesting subject for further studies.
Our assay system uses gene overexpression after transient
transfection since most known apoptosis-inducing genes,
like the ICE family of cysteine proteases, the “death do-
main” proteins and p53, achieve their effect at elevated con-
centrations. This might be the result of overcoming inhibi-
tors and forming protein–protein interactions that stimulate
the signal cascades leading to cell death. In any case, the
power of our assay is demonstrated here by the identifica-
tion of an unexpected and dominant property of the NDF
precursor. We believe that this screen will uncover addi-
tional genes that lie at critical points in the genetically de-
termined pathway that leads to programmed cell death.
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